KPIs & Operating Metrics(New)
Growth Metrics

AbbVie (ABBV) Capital Expenditures (QoQ) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -19.45%
Dec 31, 2025 -13.65%
Sep 30, 2025 41.64%
Jun 30, 2025 14.47%
Mar 31, 2025 -19.24%
Dec 31, 2024 16.87%
Sep 30, 2024 3.32%
Jun 30, 2024 24.87%
Mar 31, 2024 -5.85%
Dec 31, 2023 -6.39%
Sep 30, 2023 23.03%
Jun 30, 2023 1.71%
Mar 31, 2023 -17.84%
Dec 31, 2022 20.34%
Sep 30, 2022 23.78%
Jun 30, 2022 -11.73%
Mar 31, 2022 -13.37%
Dec 31, 2021 -13.82%
Sep 30, 2021 11.28%
Jun 30, 2021 3.72%
Mar 31, 2021 -32.62%
Dec 31, 2020 28.57%
Sep 30, 2020 22.60%
Jun 30, 2020 41.60%
Mar 31, 2020 -23.31%
Dec 31, 2019 5.84%
Sep 30, 2019 20.31%
Jun 30, 2019 19.63%
Mar 31, 2019 -13.01%
Dec 31, 2018 -56.38%
Sep 30, 2018 147.37%
Jun 30, 2018 -4.20%
Mar 31, 2018 -34.62%
Dec 31, 2017 44.44%
Sep 30, 2017 0.00%
Jun 30, 2017 32.63%
Mar 31, 2017 -16.67%
Dec 31, 2016 0.88%
Sep 30, 2016 -13.74%
Jun 30, 2016 8.26%
Mar 31, 2016 -16.55%
Dec 31, 2015 14.17%
Sep 30, 2015 10.43%
Jun 30, 2015 -20.69%
Mar 31, 2015 -5.23%
Dec 31, 2014 -15.00%
Sep 30, 2014 26.76%
Jun 30, 2014 3.65%
Mar 31, 2014 -9.27%
Dec 31, 2013 13.53%
Sep 30, 2013 11.76%
Jun 30, 2013 35.23%
Mar 31, 2013 -7.37%
Dec 31, 2012 627.78%
Sep 30, 2012 -119.15%
Jun 30, 2012 -41.98%